These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1208024)

  • 1. Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients.
    Gold J
    Oncology; 1975; 32(1):1-10. PubMed ID: 1208024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrazine sulfate: a current perspective.
    Gold J
    Nutr Cancer; 1987; 9(2-3):59-66. PubMed ID: 3104888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.
    Gold J
    Nutr Cancer; 1981; 3(1):13-9. PubMed ID: 7050921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience.
    Chlebowski RT; Bulcavage L; Grosvenor M; Tsunokai R; Block JB; Heber D; Scrooc M; Chlebowski JS; Chi J; Oktay E
    Cancer; 1987 Feb; 59(3):406-10. PubMed ID: 3791153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.
    Kosty MP; Fleishman SB; Herndon JE; Coughlin K; Kornblith AB; Scalzo A; Morris JC; Mortimer J; Green MR
    J Clin Oncol; 1994 Jun; 12(6):1113-20. PubMed ID: 8201372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.
    Chlebowski RT; Bulcavage L; Grosvenor M; Oktay E; Block JB; Chlebowski JS; Ali I; Elashoff R
    J Clin Oncol; 1990 Jan; 8(1):9-15. PubMed ID: 1688616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of a clinical study of the preparation hydrazine sulfate].
    Filov VA; Danova LA; Gershanovich ML; Ivin BA; Dement'eva NP; Breĭvis PV; Ragaĭshene VP; Kas'ianenko IV; Lisitsa AM; Mindlin SS
    Vopr Onkol; 1990; 36(6):721-6. PubMed ID: 2198698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of hydrazine sulfate in advanced cancer patients.
    Spremulli E; Wampler GL; Regelson W
    Cancer Chemother Pharmacol; 1979; 3(2):121-4. PubMed ID: 389477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].
    Filov VA; Burova TM
    Biull Eksp Biol Med; 1984 Jan; 97(1):73-4. PubMed ID: 6692028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.
    Chlebowski RT; Heber D; Richardson B; Block JB
    Cancer Res; 1984 Feb; 44(2):857-61. PubMed ID: 6692384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
    Loprinzi CL; Kuross SA; O'Fallon JR; Gesme DH; Gerstner JB; Rospond RM; Cobau CD; Goldberg RM
    J Clin Oncol; 1994 Jun; 12(6):1121-5. PubMed ID: 8201373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
    Loprinzi CL; Goldberg RM; Su JQ; Mailliard JA; Kuross SA; Maksymiuk AW; Kugler JW; Jett JR; Ghosh C; Pfeifle DM
    J Clin Oncol; 1994 Jun; 12(6):1126-9. PubMed ID: 8201374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Unproven methods of cancer management: hydrazine sulfate.
    CA Cancer J Clin; 1976; 26(2):108-10. PubMed ID: 816429
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydrazine sulfate in the treatment of cancer.
    Gold J
    Cancer Treat Rep; 1976 Jul; 60(7):964-5. PubMed ID: 1009532
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial of hydrazine sulfate (NSC-150014) in patients with cancer.
    Ochoa M; Wittes RE; Krakoff IH
    Cancer Chemother Rep; 1975; 59(6):1151-4. PubMed ID: 769954
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of clinical study antitumor action of hydrazine sulfate.
    Gershanovich ML; Danova LA; Ivin BA; Filov VA
    Nutr Cancer; 1981; 3(1):7-12. PubMed ID: 7050922
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients.
    Filov VA; Gershanovich ML; Danova LA; Ivin BA
    Invest New Drugs; 1995; 13(1):89-97. PubMed ID: 7499115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrazine sulfate and preneoplastic exfoliated cells.
    Norman RL
    Oncology; 1975; 32(5-6):221-2. PubMed ID: 1228537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.